Publicacions destacades

• Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

  Giné, E; de la Cruz, F; Ubieto, AJ; Jimenez, JL; García-Sancho, AM;

  (...)

  Sanz, RG; Nadeu, F; Beà, S; Campo, E; López-Guillermo, A.

  Veure llistat complet d'autors

  Referència:

  Journal Of Clinical Oncology 2022.

• Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [¹⁸F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125

  Glickman, A; Paredes, P; Carreras-Diéguez, N; Niñerola-Baizán, A; Gaba, L;

  (...)

  Romero, I; Fernández-Galán, E; Carrasco, JL; Gil-Ibáñez, B; Torné, A.

  Veure llistat complet d'autors

  Referència:

  European Radiology 2022.

• Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines

  Canals, J; Navarro, A; Vila, C; Canals, JM; Díaz, T;

  Acosta-Plasencia, M; Cros-Font, C; Han, B; He, YY; Monzó, M.

  Referència:

  Journal Of Experimental & Clinical Cancer Research 2022.

• Role of a portable gamma-camera with optical view for margins assessment of pulmonary nodules resected by radioguided surgery

  Vollmer, I; Sánchez-Izquierdo, N; Martínez, D; Sánchez-Lorente, D; Casanueva-Eliceiry, S;

  Boada, M; Guirao, A; Romero-Zayas, I; Vidal-Sicart, S; Paredes, P.

  Referència:

  European Journal Of Nuclear Medicine And Molecular Imaging 2021.

• Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients

  de Aledo-Castillo, JMG; Casanueva-Eliceiry, S; Soler-Perromat, A; Fuster, D; Pastor, V;

  (...)

  Viñolas, N; Reyes, R; Vollmer, I; Paredes, P; Puig-Butillé, JA.

  Veure llistat complet d'autors

  Referència:

  European Journal Of Nuclear Medicine And Molecular Imaging 2021.

• Sentinel Lymph Node Biopsy in Breast Cancer with 99mTc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer

  Vidal-Sicart, S; Rioja, ME; Prieto, A; Goñi, E; Gómez, I;

  Albala, MD; Lumbreras, L; León, LF; Gómez, JR; Campos, F.

  Referència:

  Journal Of Nuclear Medicine 2021.

• PET/CT Integrated With CT Colonography in Preoperative Obstructive Colorectal Cancer by Incomplete Optical Colonoscopy A Prospective Study

  Sanchez-Izquierdo, Nuria; Pages, Mario; Mayoral, Maria; Rubello, Domenico; Colletti, Patrick M.;

  Campos, Francisco; Romero, Inmaculada; Casanueva, Sebastian; Fritsch, Andrea; Fuster, David;.

  Referència:

  Clinical Nuclear Medicine 2020.

• Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma

  Sanchez-Izquierdo, Nuria; Perlaza, Pilar; Pages, Mario; Buxo, Elvira; Rios, Jose;

  (...)

  Mayoral, Maria; Casanueva, Sebastian; Fernandez-Esparrach, Gloria; Gines, Angels; Fuster, David.

  Veure llistat complet d'autors

  Referència:

  Clinical Nuclear Medicine 2020.

• Diagnostic accuracy of imaging studies for initial staging of T2b-T4b melanoma patients

  Riquelme-Mc Loughlin, Constanza; Podlipnik, Sebastian; Bosch-Amate, Xavier; Riera-Monroig, Jose; Barreiro, Alicia;

  (...)

  Sanchez, Marcelo; Vidal-Sicart, Sergi; Carrera, Cristina; Malvehy, Josep; Puig, Susana.

  Veure llistat complet d'autors

  Referència:

  Journal Of The American Academy Of Dermatology 2019.

• Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?

  Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G;

  (...)

  Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D .

  Veure llistat complet d'autors

  Referència:

  Clinical Nuclear Medicine 2018.